IDH1 and acute myeloid leukemia: A recent experiment identified a new metabolic vulnerability in AML cells mutated in IDH1, which significantly disrupts lipid metabolism and is characterized by a lack of monoacylglycerides and lysophospholipids and an increase in acylcarnitine species.